How Genetics and Early-Life Exposures Shape the Timing of Multiple Sclerosis Diagnosis
The article “Genetic and early life factors influence on time-to-multiple sclerosis diagnosis: A UK Biobank study” by Nova and colleagues examines how genetic susceptibility and early-life exposures influence the timing of multiple sclerosis diagnosis. Rather than treating multiple sclerosis risk as a fixed lifetime probability, the authors adopt a time-to-event framework, allowing them to evaluate how risk changes across age. This approach is particularly important because many previous studies relied on retrospective case-control designs, which estimate cumulative risk but do not adequately account for differences in follow-up duration, censoring, or age-specific variation in disease susceptibility.
Biological and Epidemiological Context of Multiple Sclerosis
Multiple sclerosis is a chronic inflammatory disease of the central nervous system characterized by immune-mediated demyelination, gliosis, and neuronal damage. Its etiology is complex, involving genetic predisposition, environmental exposures, immune dysregulation, and likely gene-environment interactions. Established risk factors include Epstein-Barr virus infection, infectious mononucleosis, tobacco smoking, high body mass index, low vitamin D status, and specific genetic variants, particularly within the HLA region. However, these factors are not sufficient by themselves to explain why some individuals develop the disease earlier than others, making the temporal dimension of risk a central question.
Study Design and Analytical Strategy
The investigators used UK Biobank data from 345,027 unrelated White participants born in England, among whom 1,669 had a recorded multiple sclerosis diagnosis. The observation period extended from birth until multiple sclerosis diagnosis, death, loss to follow-up, or 31 December 2022. Genetic liability was assessed using a multiple sclerosis polygenic risk score, while early-life variables included sex, year and season of birth, number of older siblings, breastfeeding, maternal smoking around birth, multiple birth status, geographic birth cluster, and a BMI polygenic risk score. Smoking and infectious mononucleosis were modelled as time-varying exposures, an important methodological decision that reduced the risk of immortal time bias.
Genetic Risk and Sex Show Age-Dependent Effects
A central finding of the study is that both genetic susceptibility and sex exert stronger effects at younger ages. The hazard ratio associated with higher multiple sclerosis polygenic risk declined with age, indicating that elevated genetic burden is not only linked to greater disease risk but also to earlier diagnosis. For example, a two-standard-deviation increase in the multiple sclerosis polygenic risk score was associated with a hazard ratio of 6.40 at age 20 but 2.23 at age 60. Similarly, the female-to-male hazard ratio decreased from 3.88 at age 20 to 2.15 at age 60, suggesting that biological factors contributing to female predominance in multiple sclerosis are especially influential during earlier adulthood.
Environmental and Early-Life Associations
The study also confirmed several known environmental associations. Individuals who had ever smoked on most or all days showed increased multiple sclerosis hazard, with a hazard ratio of 1.69, while those with a previous infectious mononucleosis diagnosis had a hazard ratio of 2.03. Higher BMI polygenic risk was also associated with increased hazard, supporting the broader evidence linking adiposity-related biology to multiple sclerosis susceptibility. Season of birth was another notable factor: compared with birth in autumn, birth in spring, summer, or winter was associated with higher hazard, a pattern the authors discuss in relation to prenatal sunlight exposure and maternal vitamin D status. In contrast, breastfeeding, maternal smoking around birth, multiple birth status, and number of older siblings were not statistically significant predictors in the main model.
Gene-Environment Interaction and Risk Prediction
An important contribution of the article is its evaluation of interactions between genetic susceptibility and environmental or demographic factors. The authors observed positive additive interactions between higher multiple sclerosis polygenic risk and female sex, infectious mononucleosis, smoking, and later year of birth. These findings suggest that genetic predisposition may combine with immune-related or environmental exposures to accelerate disease manifestation. The model also demonstrated reasonable predictive discrimination, with a bias-corrected Harrell’s C-index of 0.74. In cumulative incidence analyses, individuals with a polygenic risk score at the 99th percentile, together with both smoking and infectious mononucleosis, had the highest estimated probability of multiple sclerosis diagnosis by age 80: approximately 10% in females and 4% in males.
Scientific Implications and Limitations
This study demonstrates that multiple sclerosis risk is dynamic rather than uniform across the lifespan. By showing that genetic risk and female sex have stronger effects at younger ages, the authors argue that conventional case-control studies may underestimate age-specific contributions to disease onset. Nevertheless, several limitations must be acknowledged. Multiple sclerosis diagnosis was used as a proxy for disease onset, diagnoses were based on linked records and self-report rather than uniform clinical adjudication, infectious mononucleosis was an imperfect proxy for Epstein-Barr virus biology, and the findings may not generalize beyond White individuals born in England. Despite these constraints, the study provides a valuable methodological framework for future survival-based genetic and epidemiological analyses, particularly those aiming to identify individuals at elevated risk earlier in life.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Nova, A., Di Caprio, G., Bernardinelli, L., & Fazia, T. (2024). Genetic and early life factors influence on time-to-multiple sclerosis diagnosis: A UK Biobank study. Multiple Sclerosis Journal, 30(8), 994-1003.
